Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

NCT01877187 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: Lipiodol

Sponsor

Yale University

Collaborators

[object Object]